A shield against a monster:Hepatitis C in hemodialysis patients  

作　　者：Seyed-Moayed Alavian 

机构地区：[1]Baqiyatallah Research Center for Gastroenterology and Liver Disease,Baqiyatallah Research Center for Gastroenterology and Liver Disease,Tehran 1998136194,Iran

出　　处：《World Journal of Gastroenterology》2009年第6期641-646,共6页世界胃肠病学杂志（英文版）

摘　　要：Hepatitis C virus(HCV)infection is highly prevalent among patients on hemodialysis(HD).The prevalence of HCV infection in HD patients varies markedly from country to country.Some factors are especially related to these high prevalence rates,such as blood transfusions and length of dialysis time. Nosocomial routes of transmission including the use of contaminated equipment and patient-to-patient exposure is considered more important.Several prophylactic measures have been suggested to avoid infection by HCV in the HD environment.Hepatitis C virus （HCV） infection is highly prevalent among patients on hemodialysis （HD）. The prevalence of HCV infection in HD patients varies markedly from country to country. Some factors are especially related to these high prevalence rates, such as blood transfusions and length of dialysis time. Nosocomial routes of transmission including the use of contaminated equipment and patient-to-patient exposure is considered more important. Several prophylactic measures have been suggested to avoid infection by HCV in the HD environment.

关 键 词：DIALYSIS Epidemiology Hepatitis C virus INCIDENCE Isolation Nosocomial transmission Prevalence Prevention Universal precaution 

分 类 号：R459.5[医药卫生—治疗学] R512.63[医药卫生—临床医学]